TELOTelomir Pharmaceuticals Inc. Common Stock

1.130USD-3.42%Mkt Cap: 77.72M $P/E:

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is…

Key Statistics

Company
Market Cap77.72M $
Enterprise Value72.68M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-10.41M $
Revenue/Share
Last Price1.130 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-4.04
PEG
EV/EBITDA
EV/Revenue
P/S
P/B7.85
EPS (TTM)-1.06
EPS (Forward)-0.28
52W Range
0.888520% of range2.091
52W High2.091 USD
52W Low0.8885 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-176.10%
ROA-141.84%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-3.69M $
CapEx (TTM)
FCF Margin
FCF Yield2.76%
Net Debt-5.03M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity2.72
Current Ratio16.14
Quick Ratio15.55
Book Value/Sh0.1440 USD
Cash/Share0.0750 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.68.77M
Float47.51M
Insiders45.55%
Institutions4.31%
Short Interest
Short Ratio9.6d
Short % Float1.75%
Short % Out.1.40%
Shares Short963.35K
Short (prev mo.)953.31K
Technical
SMA 501.198 (-5.7%)
SMA 2001.285 (-12.1%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)81.57K
Avg Vol (10d)48.63K
Technical Indicators
RSI (14)47.6
MACD-0.0249
MACD Signal-0.0238
MACD Hist.-0.0011
BB Upper1.270 USD
BB Middle1.160 USD
BB Lower1.050 USD
BB Width18.89%
ATR (14)0.0778 USD
Vol Ratio (20d)0.54x